Additional file 2 of Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline

  • Julia Stockmann (Contributor)
  • Inge M.W. Verberk (Contributor)
  • Nina Timmesfeld (Contributor)
  • Robin Denz (Contributor)
  • Brian Budde (Contributor)
  • Julia Lange-Leifhelm (Contributor)
  • Philip Scheltens (Contributor)
  • Wiesje M. van der Flier (Contributor)
  • Andreas Nabers (Contributor)
  • Charlotte E Teunissen (Contributor)
  • Klaus Gerwert (Contributor)



Additional file 2: Supplementary Table 2. Risks and events by year with amide I maximum ≥1644 cm− 1,
Date made available1 Jan 2020
PublisherUnknown Publisher

Cite this